Massive brain cancer trial aims to find better treatments
Disease control
Recruiting now
This large international trial is testing several different drugs, including temozolomide, lomustine, regorafenib, and paxalisib, in people with newly diagnosed or recurrent glioblastoma, an aggressive brain cancer. The study uses an adaptive design, meaning it can quickly drop i…
Phase: PHASE2, PHASE3 • Sponsor: Global Coalition for Adaptive Research • Aim: Disease control
Last updated Jul 15, 2026 00:00 UTC